LC

Lightchain Capital

North America, Missouri, United States, St Louis

Description

Lightchain Capital focuses investments on early-stage life sciences companies.

Investor Profile

Lightchain Capital has made 5 investments, with 1 in the past 12 months and 40% as lead.

Stage Focus

  • Seed (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Enterprise Applications
  • Information Technology
  • Software
  • Therapeutics
  • Genetics
  • Health Diagnostics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lightchain Capital frequently co-invest with?

LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
Co-Investments: 1
PH
North America, New York, United States, New York
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Cobro Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2
GM
North America, New York, United States, New York
Co-Investments: 1
Bio-Rad Laboratories
North America, California, United States, Hercules
Co-Investments: 1
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 2
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Lightchain Capital?

Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJan 8, 2025
Amount Raised: $105,000,000
SimpleRose

Saint Louis, Missouri, United States

SimpleRose is a technology company that allows customers to optimize and accelerate decision-making.

Enterprise ApplicationsInformation TechnologySoftware
Series AApr 6, 2023
Amount Raised: $23,001,264
AI Proteins

Boston, Massachusetts, United States

AI Proteins is a biotechnology company that focuses on designing and engineering of synthetic miniprotein therapeutics.

Artificial Intelligence (AI)BiotechnologyTherapeutics
SeedNov 3, 2022
Amount Raised: $18,200,000
NextRNA Therapeutics

Cambridge, Massachusetts, United States

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

BiotechnologyHealth CareTherapeutics
Series AMar 1, 2022
Amount Raised: $46,800,000
SimpleRose

Saint Louis, Missouri, United States

SimpleRose is a technology company that allows customers to optimize and accelerate decision-making.

Enterprise ApplicationsInformation TechnologySoftware
SeedOct 10, 2018
Amount Raised: $24,000,000